A medication originally developed to treat epilepsy in Europe has demonstrated remarkable efficacy in reducing sleep apnea episodes by up to 47% in large-scale clinical trials. The oral drug offers a non-invasive alternative to CPAP machines, which many patients struggle to use consistently.
Sleep apnea affects millions of people worldwide,
